Marshall Wace’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-507,781
Closed -$16.9M – 3145
2024
Q3
$16.9M Buy
507,781
+45,158
+10% +$1.55M 0.02% 571
2024
Q2
$12.5M Sell
462,623
-103,875
-18% -$2.05M 0.02% 639
2024
Q1
$12.2M Buy
+566,498
New +$12.4M 0.02% 680

Marshall Wace's LBPH Position: Q4 2024 in Review

Marshall Wace sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 507,781 shares — an estimated $16.9M sold.

Marshall Wace first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $16.9M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Marshall Wace reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Marshall Wace sold 507,781 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $16.9M.
  • Marshall Wace first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Marshall Wace's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $16.9M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.